Percentage of Potential Participants Approached Who Were Eligible for the Study
Primary
· Month 6
| Group | Value | 95% CI |
|---|---|---|
| Homelessness Prevention Services | 2.34 |
Last reviewed · How we verify
NCT03864341
ED-Home Pilot Study
Completed
NA
Results posted
Last updated 19 August 2022
What this trial tests
NA trial testing Referral to homelessness prevention services in Housing Problems in 40 participants. Completed in 23 March 2020.
Timeline
8 May 2019
Primary endpoint
23 March 2020
23 March 2020
23 March 2020
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 40 |
| Start date | 8 May 2019 |
| Primary completion | 23 March 2020 |
| Estimated completion | 23 March 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Referral to homelessness prevention services
- Substance use services
- Follow-up
Conditions studied
- Housing Problems — all drugs for Housing Problems →
- Drug Use — all drugs for Drug Use →
- Alcohol; Use, Problem — all drugs for Alcohol; Use, Problem →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 99, any sex, with Housing Problems or Drug Use. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of Eligible Participants Who Agreed to Participate in the Study
Primary
· Month 6
| Group | Value | 95% CI |
|---|---|---|
| Homelessness Prevention Services | 78.43 |
Number of Participants Who Received Referrals for Homelessness Prevention and/or Substance Use Services
Primary
· Month 6
| Group | Value | 95% CI |
|---|---|---|
| Homelessness Prevention Services | 39 |
Sponsor's own description
This is a single-arm pilot study to test the feasibility of homelessness prevention and substance use interventions to be delivered to at-risk patients in the Bellevue Hospital emergency department (ED). ED patients (n=40) found eligible for the study will complete a baseline assessment and receive referrals to appropriate services, with a final six-month follow-up assessment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03864341
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Housing Problems
Currently open trials in the same condition.
- NCT06311838 — Building Social and Structural Connections for the Prevention of Opioid Use Disorder Among Youth Experiencing Homelessne · NA · recruiting
- NCT05665179 — Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis · NA · recruiting
- NCT04845230 — Fresh RX: NHS 2020 · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
Data sources for this page
- Trial protocol + status: ClinicalTrials.gov NCT03864341 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 19 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03864341.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing